# DESCRIPTION

## FIELD OF THE DISCLOSURE

- define field of invention

## DISCUSSION OF RELATED ART

- discuss cancer statistics
- describe limitations of chemotherapy
- motivate LHRH targeting

## SUMMARY OF THE DISCLOSURE

- summarize invention

## DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

- define scope of invention
- describe preferred embodiment of Pt-LHRH conjugate
- detail synthesis of Pt-LHRH conjugate
- discuss advantages of Pt-LHRH conjugate over existing drugs

### Example 1

- describe synthesis of mal linker

### Example 2

- describe synthesis of Pt-LHRH conjugate

### Example 3

- describe cytotoxicity assay of Pt-LHRH conjugate

### Example 4

- describe drug uptake measurements of Pt-LHRH conjugate

### Example 5

- describe migration assay of Pt-LHRH conjugate

### Example 6

- conduct in-vivo experiment
- define Pt-LHRH conjugate
- describe administration and formulation

